Purification and characterization of a human bradykinin binding protein from inflammatory cells

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 3, 1998, Pages 353-367

  Rajasekariah, Poornima ^a   Warlow, Robert S ^a   Campbell, Mary E ^b   Ozsarac, Nesrin ^a,c   Dao, Phuong L ^a   Swanton, Michael K ^d   Walls, Ronald S ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Affinity chromatography; Inflammatory cells; Purification; Radioreceptor crosslinking; Radioreceptor dot assays

Indexed keywords

BINDING PROTEIN; BRADYKININ; BRADYKININ BINDING PROTEIN; BRADYKININ RECEPTOR; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CELL LYSATE; CROSS LINKING; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; MONONUCLEAR CELL; NEUTROPHIL; PROTEIN BINDING; PROTEIN PURIFICATION; RADIORECEPTOR ASSAY;

BRADYKININ; CARRIER PROTEINS; CELL LINE; CELL MEMBRANE; CHROMATOGRAPHY, AFFINITY; CROSS-LINKING REAGENTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; MOLECULAR WEIGHT; NEUTROPHILS; RADIOLIGAND ASSAY; RECEPTORS, BRADYKININ;

EID: 0031859117     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(97)00110-6     Document Type: Article

References (47)

1. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
2. W.C. Clark, Kinins and the peripheral and central nervous system, in: E.G. Erdos (Ed.), Handb. Exp. Pharmacol., Vol. 25 (Suppl.), Springer-Verlag, Berlin, 1979, pp. 311-356.
3. Steranka L.R., Manning D.C., De Hass C.J., Ferkany J.W., Borosky S.A., Connor J.R., Vavrek R.J., Stewart J.M., Snyder S.H. Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. USA. 85:1988;3245-3249.
4. Ignarro L.J. Nitric oxide-mediated vasorelaxation. Thromb. Haemost. 70:1993;148-151.
5. E.G. Erdos, Kininases, in: E.G. Erdos (Ed.), Handb. Exp. Pharmacol., Vol. 25 (Suppl), Springer-Verlag, Berlin, 1979, pp. 427-487.
6. Roscher A.A., Manganiello V.C., Jelsema C.L., Moss J. Receptors for bradykinin in intact cultured human fibroblasts. J. Clin. Invest. 72:1983;626-635.
7. Regoli D., Barabe J., Park W.K. Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol. 55:1977;855-867.
8. Braas K.M., Manning D.C., Perry D.C., Snyder S.H. Bradykinin analogues: Differential agonist and antagonist activities suggesting multiple receptors. Br. J. Pharmacol. 94:1988;3-5.
9. Llona I., Vavrek R., Stewart J., Huidobro-Toro J.P. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: Evidence for different structural prerequisites. J. Pharmacol. Exp. Ther. 241:1987;608-614.
10. Conklin B.R., Burch R.M., Steranka L.R., Axelrod J. Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts. J. Pharmacol. Exp. Ther. 244:1988;646-649.
11. Plevin R., Owen P.J. Multiple B2 kinin receptors in mammalian tissues. Trends Pharmacol. Sci. 9:1988;387-389.
12. Field J.L., Hall J.M., Morton I.K.M. Bradykinin receptors in the guinea-pig taenia caeci are similar to proposed BK3 receptors in the guinea-pig trachea and are blocked by HOE 140. Br. J. Pharmacol. 105:1992;293-296.
13. Regoli D., Gobeil F. Pharmacology of kinin receptors: Recent developments. Can. J. Physiol. Pharmacol. 73:1995;791-796.
14. Roch-Arveiller M., Caranikas S., Regoli D., Giroud J.P. Effects of bradykinin and some of its fragments on smooth muscles and chemotaxis. Eur. J. Pharmacol. 88:1983;99-103.
15. Tiffany C.W., Burch R.M. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 247:1989;189-192.
16. Ahluwalia A., Perretti M. Involvement of bradykinin B1 receptor in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol. 156:1996;269-274.
17. Bockmann S., Paegelow I. Bradykinin receptors in signal transduction pathways in peritoneal guinea pigs macrophages. Eur. J. Pharmacol. 291:1995;159-165.
18. P. Rajasekariah, R.S. Warlow, R.S. Walls, High affinity bradykinin binding to human inflammatory cells, Biochem. Mol. Biol. Int. 43 (1997) 279-290.
19. Yaqoob M., Snell C.R. Purification and characterization of B2 bradykinin receptor from rat uterus. J. Neurochem. 62:1994;17-26.
20. Warlow R.S., White R., Bernard C.C.A. Solubilization and characterization of a low affinity histamine-binding site on human blood mononuclear cells. Mol. Immunol. 23:1986;393-402.
21. Arnott R.D., White R., Jerums G. Effects of thyroid status on ouabain binding to the human lymphocyte. J. Clin. Endocr. Metab. 54:1982;1150-1156.
22. J.L. Caputo, CCD-16Lu (lung, Human), American Type Culture Collection, 6th edn., Rockville Maryland, 1988, pp. 112.
23. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270:1977;347-349.
24. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line. Int. J. Cancer. 177:1974;565-577.
25. Weiss A., Wiskocil R.L., Stobo J.D. The role of T3 surface molecules in the activation of human T cells: A two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133:1984;123-128.
26. Warlow R.S., Rajasekariah P., Lambert P., Reid J., Dao L.P., Bernard C.C.A., Walls R.S. Purification of histamine receptor proteins from detergent solubilized human peripheral blood mononuclear cells. Biochemistry. 33:1994;4800-4811.
27. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. McIntyre P., Phillips E., Skidmore E., Brown M., Webb M. Cloned murine bradykinin receptor exhibits a mixed B1 and B2 pharmacological selectivity. Mol. Pharmacol. 44:1993;346-355.
29. Alla S.A., Buschko J., Quitterer U., Maidhof A., Haasemann M., Breipohl G., Knolle J., Muller-Esterl W. Structural features of the human bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic antibodies. J. Biol. Chem. 268:1993;17277-17285.
30. Faussner A., Heinz-Erian P., Klier C., Roscher A.A. Solubilization and characterization of B2 bradykinin receptors from cultured human fibroblasts. J. Biol. Chem. 266:1991;9442-9446.
31. McEachern A.E., Shelton E.R., Bhakta S., Obernolte R., Bach C., Zuppan P., Fujisaki J., Aldrich R.W., Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc. Natl. Acad. Sci. USA. 88:1991;7724-7728.
32. Hess J.F., Borkowski J.A., Young G.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
33. Jong Y.J.I., Dalemar L.R., Wilhelm B., Baenziger N.L. Human bradykinin B2 receptors isolated by receptor-specific monoclonal antibodies are tyrosine phosphorylated. Proc. Natl. Acad. Sci. USA. 90:1993;10994-10998.
34. Trifilieff A., Lach E., Mousli M., Haddad E.-B., Landry Y., Gies J.-P. Co-solubilization of bradykinin B2 receptors and angiotensin-converting enzyme from guinea pig lung membranes. Biochem. Biophys. Acta. 1191:1994;109-116.
35. Ma J.-X., Wang D.-Z., Ward D.C., Chen L., Desai T., Chao J., Chao L. Structure and chromosomal localization of the gene (BDKRB2) encoding human bradykinin B2 receptor. Genomics. 23:1994;362-369.
36. Melrose G.J.H., Muller H.K., Vagg W.J. Correlation of bradykinin structure with ability to increase vascular permeability. Nature. 225:1970;547-548.
37. 125I -fluoresceinamine-heparin Anal. Biochem. 160:1987;105-114.
38. Ehlers M.R.W., Fox E.A., Strydom D.J., Riordan J.F. Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. USA. 86:1989;7741-7745.
39. Lantz I., Nyberg F., Terenius L. Molecular heterogeneity of angiotensin-converting enzyme in human cerebrospinal fluid. Biochem. Int. 23:1991;941-948.
40. Miska W., Croseck H., Schill W.B. Proteins of the kallikrein-kinin system in human semen. Isolation and properties of kininase II. Andrologia. 22:1990;178-184.
41. Tan F., Weerasinghe D.K., Skidgel R.A., Tamei H., Kaul R.K., Roninson I.B., Schilling J.W., Erdos E.G. The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandom repeats. J. Biol. Chem. 265:1990;13-19.
42. Odink K., Cereletti N., Bruggen J., Clerc R.G., Tarcsay L., Zwaldo G., Gerhards G., Schlegel R., Sorg C. Two calcium binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature. 330:1987;80-82.
43. Palfree R.G.E., Sirlin S., Dumont F.J., Hammerling U. N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C.2. J. Immunol. 140:1988;305-310.
44. Shevach E.M., Korty P.E. Ly-6 a multigene family in search of a function. Immunol. Today. 10:1989;195-200.
45. Anderson R.G.W., Kamen B.A., Rothberg K.G., Lacey S.W. Potocytosis: Sequestration and transport of small molecules by caveolae. Science. 255:1992;410-411.
46. Anderson R.G.W. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. USA. 90:1993;10909-10913.
47. Anderson R.G.W. Plasmalemmal caveolae and GPI-anchored membrane proteins. Curr. Opin. Cell Biol. 5:1993;647-652.